MSH6 and central nervous system cancer: Its mutational analysis identified previously identified hereditary gene changes such as MSH6 known to confer susceptibility to glioma, BRCA1 germline mutation which is extremely rare in gliomas, as well as a novel mutation EWSR1 in glioma.